Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "avtor" (Mo%C5%BEina Eva) .

1 - 10 / 120
Na začetekNa prejšnjo stran12345678910Na naslednjo stranNa konec
1.
Machine learning heralding a new development phase in molecular dynamics simulations
Eva Prašnikar, Martin Ljubič, Andrej Perdih, Jure Borišek, 2024, pregledni znanstveni članek

Objavljeno v DiRROS: 09.04.2024; Ogledov: 63; Prenosov: 27
.pdf Celotno besedilo (3,32 MB)
Gradivo ima več datotek! Več...

2.
The role of extracellular vesicles in phenotypic cancer transformation
Eva Ogorevc, Veronika Kralj-Iglič, Peter Veranič, 2013, pregledni znanstveni članek

Povzetek: Background. Cancer has traditionally been considered as a disease resulting from gene mutations. New findings in biology are challenging gene-centered explanations of cancer progression and redirecting them to the non-genetic origins of tumorigenicity. It has become clear that intercellular communication plays a crucial role in cancer progression. Among the most intriguing ways of intercellular communication is that via extracellular vesicles (EVs). EVs are membrane structures released from various types of cells. After separation from the mother membrane, EVs become mobile and may travel from the extracellular space to blood and other body fluids. Conclusions. Recently it has been shown that tumour cells are particularly prone to vesiculation and that tumour-derived EVs can carry proteins, lipids and nucleic acids causative of cancer progression. The uptake of tumour-derived EVs by noncancerous cells can change their normal phenotype to cancerous. The suppression of vesiculation could slow down tumour growth and the spread of metastases. The purpose of this review is to highlight examples of EV-mediated cancer phenotypic transformation in the light of possible therapeutic applications.
Objavljeno v DiRROS: 03.04.2024; Ogledov: 54; Prenosov: 24
.pdf Celotno besedilo (864,38 KB)
Gradivo ima več datotek! Več...

3.
4.
5.
Radiotherapy in combination with vascular-targeted therapies
Eva Ćirić, Gregor Serša, 2010, pregledni znanstveni članek

Objavljeno v DiRROS: 15.03.2024; Ogledov: 85; Prenosov: 27
.pdf Celotno besedilo (1,06 MB)

6.
Characterization of hFOB 1.19 cell line for studying Zn-based degradable metallic biomaterials
Eva Jablonská, Lucie Mrázková, Jiří Kubásek, Dalibor Vojtěch, Irena Paulin, Tomáš Ruml, Jan Lipov, 2024, izvirni znanstveni članek

Povzetek: In vitro testing is the first important step in the development of new biomaterials. The human fetal osteoblast cell line hFOB 1.19 is a very promising cell model; however, there are vast discrepancies in cultivation protocols, especially in the cultivation temperature and the presence of the selection reagent, geneticin (G418). We intended to use hFOB 1.19 for the testing of Zn-based degradable metallic materials. However, the sensitivity of hFOB 1.19 to zinc ions has not yet been studied. Therefore, we compared the toxicity of zinc towards hFOB 1.19 under different conditions and compared it with that of the L929 mouse fibroblast cell line. We also tested the cytotoxicity of three types of Zn-based biomaterials in two types of media. The presence of G418 used as a selection reagent decreased the sensitivity of hFOB 1.19 to Zn2+. hFOB 1.19 cell line was more sensitive to Zn2+ at elevated (restrictive) temperatures. hFOB 1.19 cell line was less sensitive to Zn2+ than L929 cell line (both as ZnCl2 and extracts of alloys). Therefore, the appropriate cultivation conditions of hFOB 1.19 during biomaterial testing should be chosen with caution.
Ključne besede: zinc degradable materials, in vitro cytotoxicity testing, hFOB 1.19 osteoblasts
Objavljeno v DiRROS: 28.02.2024; Ogledov: 115; Prenosov: 48
.pdf Celotno besedilo (1,81 MB)
Gradivo ima več datotek! Več...